Skip to content

SHARECONTRACEPT, a shared decision-making tool for hormonal contraception

SHARECONTRACEPT, a digital decision-making-tool. Does it improve adherence to the chosen contraceptive method?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58279944
Enrollment
1708
Registered
2019-04-15
Start date
2019-07-01
Completion date
Unknown
Last updated
2023-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception Pregnancy and Childbirth

Interventions

This study will include an intervention group and a control group and data will be collected during a year in 6 autonomous regions in Spain. The health professionals participating in each unit will be

Sponsors

Universitat Rovira i Vigili
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 28/05/2019: 1. Women aged 16 or older 2. Women aged 49 years or younger 3. Have primary studies and are proficient in Spanish and/or Catalan 4. Have access to the internet 5. Agree to voluntarily participate in the study Previous participant inclusion criteria: 1. Women aged 18 or older 2. Women aged 49 years or younger 3. Have primary studies and are proficient in Spanish and/or Catalan 4. Have access to the internet 5. Agree to voluntarily participate in the study

Exclusion criteria

Exclusion criteria: 1. Women aged 17 years or younger 2. Women aged 50 or older 3. Women who wish to have children before one year from the date of the consultation 4. Don't have access to internet 5. Don't understand Catalan and/or Spanish

Design outcomes

Primary

MeasureTime frame
Adherence to treatment: compliance with dosage and method of administration and persistence in the duration of prescribed treatment, evaluated through a structured interview ad-hoc including questions about a) the compliance with the contraceptive method chosen in the clinical consultation, b) information about the usage of this method and c) unwanted pregnancy incidences. Assessed by a phone call at 1 month, 6 months and 1 year.

Secondary

MeasureTime frame
1. Sociodemographic characteristics of the patient: age, educational level, occupation, marital status/couple, assessed at a structured interview ad-hoc at the first contact in the clinical consultation 2. Medical history: smoking habits, HBP, uterine malformations, diabetes, assessed at a structured interview ad-hoc at the first contact in the clinical consultation 3. Obstetric and gynecological antecedents: menstrual formula, menarche, term or premature pregnancies, ectopic pregnancies, spontaneous abortions, IVE, gynecological reviews according to the guidelines of each community, active sexually transmitted diseases, living children, desire to have children, assessed at a structured interview ad-hoc at the first contact in the clinical consultation 4. Contraceptive method: contraceptive method contemplated by the patient before counseling, prejudices against other contraceptives, experiences with other methods, possible beneficial non-contraceptive effects, importance of the cost in her choice, women's behavior with respect to compliance (Morisky-Green's adherence to treatment), finally chosen contraceptive, incidents with the chosen method, management of the incidences, decisional conflict of the woman before the choice of the contraceptive method (O'Connor Scale), assessed at a structured interview ad-hoc at the first contact in the clinical consultation 5. Professional: satisfaction of the advisor or clinician with the use of the Digital HATD (Likert scale), acquired knowledge (ad-hoc knowledge test) assessed after the first year recruiting women for the study

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026